PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Jan-2023 Defence Therapeutics Inc.: mRNA WITH DEFENCE’S ACCUMTM PROGRAM HAS BEEN INITIATED Defence Therapeutics Inc.
10-Jan-2023 Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial Biotest AG
09-Jan-2023 No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes B3C newswire
09-Jan-2023 Formycon announces binding Term Sheet between Klinge Biopharma and Coherus BioSciences for the exclusive commercialization of FYB203, a biosimilar candidate to Eylea®1, in the United States Formycon AG
09-Jan-2023 CureVac Appoints Alexander Zehnder as CEO From April 1, 2023 CureVac
09-Jan-2023 BRAIN Biotech AG: Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site BRAIN Biotech AG
09-Jan-2023 ProtonDx and Katalyst Announce Strategic Partnership to Distribute Dragonfly™ In Vitro Diagnostic B3C newswire
09-Jan-2023 Spexis reports solid safety and pharmacokinetics results from first-in-human study with inhaled murepavadin, a novel macrocycle compound Spexis AG
09-Jan-2023 MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024 MorphoSys AG
06-Jan-2023 PM Society Training Courses – Start 2023 with some fresh education and personal development PM Society
06-Jan-2023 Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced Volta Medical
06-Jan-2023 New Year and two new zones at Pharmapack Europe in 2024 Pharmapack Europe
06-Jan-2023 Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes Akili, Inc.
06-Jan-2023 CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs CureVac
05-Jan-2023 Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes B3C newswire
05-Jan-2023 Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma Dermapharm Holding SE
05-Jan-2023 FDA accepts nirsevimab application as first protective option against RSV disease for all infants Sanofi
05-Jan-2023 X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership X-Chem
05-Jan-2023 BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund B3C newswire
05-Jan-2023 MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability MorphoSys AG